Ascentage Pharma Group In... (AAPG)
NASDAQ: AAPG
· Real-Time Price · USD
38.85
-0.93 (-2.34%)
At close: Oct 03, 2025, 1:29 PM
-2.34% (1D)
| Bid | 38.45 |
| Market Cap | 3.61B |
| Revenue (ttm) | 1.06B |
| Net Income (ttm) | -928.72M |
| EPS (ttm) | -2.13 |
| PE Ratio (ttm) | -18.24 |
| Forward PE | 4.82 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 39.41 |
| Volume | 3,918 |
| Avg. Volume (20D) | 9,498 |
| Open | 39.39 |
| Previous Close | 39.78 |
| Day's Range | 38.85 - 39.90 |
| 52-Week Range | 16.50 - 48.45 |
| Beta | 0.92 |
| Ex-Dividend Date | n/a |
About AAPG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AAPG
Website n/a
1 month ago
+5.53%
Ascentage Pharma Group shares are trading higher a...
Unlock content with
Pro Subscription
4 months ago
+10.03%
Ascentage Pharma shares are trading higher after the company highlighted new clinical data of Alrizomadlin at ASCO 2025.
